Previous close | 3.2700 |
Open | 3.5000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 420.00 |
Expiry date | 2024-08-02 |
Day's range | 3.2700 - 3.5000 |
Contract range | N/A |
Volume | |
Open interest | 13 |
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
(Bloomberg) -- S&P Global Inc. named Martina Cheung, the president of its credit ratings division, as its next chief executive officer. Most Read from BloombergBiden Struggles as He Spars With Trump on Economy: Debate TakeawaysBiden’s Disastrous Debate Accelerates Doubts Over CandidacySupreme Court Poised to Allow Emergency Abortions in IdahoBiden Struggles Against Trump in High-Stakes 2024 DebateSpaceX Tender Offer Said to Value Company at Record $210 BillionCheung will become CEO effective Nov
Cheung, who has held multiple leadership roles at S&P Global in her 14-year stint, will succeed Douglas Peterson, the company's chief executive since 2013. S&P Global announced that retiring CEO Peterson will remain with the board until May 2025, and will be a special adviser to the company till Dec. 31, 2025. This trend bodes well for companies such as S&P Global, known for its rating agency business and stock market indexes.